Stephen Andrew Welch - Dec 14, 2022 Form 4 Insider Report for Mallinckrodt plc (MNKTQ)

Role
EVP & Head of Spec Generics
Signature
/s/ Mark Tyndall, Attorney-in-Fact
Stock symbol
MNKTQ
Transactions as of
Dec 14, 2022
Transactions value $
$0
Form type
4
Date filed
12/22/2022, 04:50 PM
Previous filing
Aug 26, 2022
Next filing
Mar 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MNKTQ Ordinary Shares Award $0 +37.5K $0.00 37.5K Dec 14, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported ordinary shares represent restricted stock units, which will be settled in an equal number of MNK ordinary shares and will vest ratably on each of the first three anniversaries of August 17, 2022.

Remarks:

This Form 4 constitutes a notice to the Issuer for purposes of Part V of the Companies Act 2014